Efficacy of a Therapeutic Combination of Dronabinol and PEA for Tourette Syndrome

Completed · Phase 2

Conditions studied: Tourette Syndrome

In brief

This is an investigator-initiated proof of concept study with the purpose to examine the safety, tolerability and feasibility of Dronabinol (synthetic Δ9-THC) and PEA for the treatment of adults with Tourette syndrome.

Key facts

Study ID
NCT03066193
Run by
Yale University
People needed
17
Starts
2017-02-01
Expected to finish
2018-06-28
Last updated by the study team
2020-02-24

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.